alternatives to glp-1 agonists Natural Alternatives: Supporting Metabolic Health Evolution of GLP‐1 Receptor Agonists

In their announcement about the retatrutide study, Eli Lilly medical experts said that about 11% of study volunteers who received the highest dose of the drug stopped taking it and dropped out of the study due to unpleasant side effects

cDNA constructs of rat TRPV1 were transiently transfected into cells via Lipofectamine 2000 (Invitrogen)

Phase 2 trials published in the New England Journal of Medicine showed the 12 mg dose group losing 24.2% of body weight at 48 weeks

Epidemiology 20 , 512522 (2009)

Given the relatively recent approval and widespread uptake of GLP-1RAs, the studys follow-up duration may not have been sufficient to fully capture their long-term effects on cancer risk